BTIG Reiterates Buy Rating on INVA, Sets $42 Target
BTIG maintains its buy rating for INVA, targeting $42, as shares trade near $22.67, a 77.66% upside from the current price.
Key Points
- BTIG reiterated its buy rating on INVA with a price target of $42 on June 22, 2026.
- BTIG's $42 price target implies 77.66% upside from Innoviva, Inc.'s ($INVA) current $23.64 share price.
- INVA shares traded around $22.67 on Tuesday, reflecting ongoing market interest.
- Recent insider activity includes sales by top executives on May 20, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
BTIG maintained its buy rating on INVA, setting a price target of $42. This reiteration was announced on June 22, 2026, reflecting continued confidence in the company's potential. INVA shares were trading around $22.67 on Tuesday, suggesting a positive outlook from the analyst community.
BTIG vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in INVA
BlackRock, Inc. grew its holdings in INVA by 631,070 shares, ending with 11,307,845 shares worth about $263.5 million. Dimensional Fund Advisors LP added 76,026 shares, bringing its total to 4,436,427 shares valued at approximately $103.4 million. Vanguard Portfolio Management LLC opened a new position with 4,224,951 shares valued at nearly $98.4 million. Meanwhile, Renaissance Technologies LLC reduced its stake by 154,540 shares, leaving it with 4,055,632 shares worth about $94.5 million. State Street Corp increased its holdings by 263,557 shares to 3,060,377 shares, valued at roughly $71.3 million.
Innoviva, Inc. Stock Up 12.7%
Shares of INVA traded near $22.67 on Tuesday. While specific market cap and P/E ratio details aren't available, the stock's recent activity and analyst rating suggest ongoing interest.
$INVA price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Insider Buying and Selling at Innoviva, Inc.
On May 20, 2026, several top executives at INVA, including CFO Stephen Basso and CEO Pavel Raifeld, sold shares at an average price of $22.24. Basso sold 559 shares, while Raifeld sold 1,130 shares. Chief Accounting Officer Marianne Zhen also sold 1,127 shares. Earlier, on May 15, 2026, Raifeld and Basso each bought 1,123 shares, and Josephine Linden acquired 9,166 shares on May 18, 2026.
Analysts Set New Price Targets
On June 22, 2026, BTIG maintained its buy rating for INVA with a $42 price target. Earlier, on June 1, 2026, HC Wainwright & Co. reiterated a buy rating with a $46 target. These ratings highlight strong analyst support for INVA.
About INVA
INVA operates in the healthcare sector, focusing on innovative solutions to improve patient outcomes. The company is committed to advancing medical technology and is based in the United States. With a team dedicated to research and development, INVA aims to lead in its industry.
Bottom Line
BTIG's reiterated buy rating and $42 price target for INVA underscore the analyst's confidence in the company's prospects. With shares trading around $22.67, investors are keeping a close watch on INVA's performance. The 13F filings and insider transactions provide a backward-looking view, offering insights into institutional sentiment and executive actions.
Get Innoviva, Inc. alerts
New 13F filings, insider trades, and analyst moves on $INVA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.